{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:08:53Z","timestamp":1791493733545,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:00:00Z","timestamp":1466640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:00:00Z","timestamp":1466640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1038\/jhg.2016.78","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T12:28:45Z","timestamp":1466684925000},"page":"923-929","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes"],"prefix":"10.1038","volume":"61","author":[{"given":"Ja Hye","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja","family":"Hyang Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eungu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,23]]},"reference":[{"key":"BFjhg201678_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain, D. P. Fabry disease. Orphanet J. Rare Dis. 5, 30 (2010).","journal-title":"Orphanet J. Rare Dis."},{"key":"BFjhg201678_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","volume":"451","author":"H Askari","year":"2007","unstructured":"Askari, H., Kaneski, C. R., Semino-Mora, C., Desai, P., Ang, A., Kleiner, D. E. et al. Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch. 451, 823\u2013834 (2007).","journal-title":"Virchows Arch."},{"key":"BFjhg201678_CR3","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","volume":"24","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann, R., Warnock, D. G., Banikazemi, M., Bultas, J., Linthorst, G. E., Packman, S. et al. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol. Dial. Transplant. 24, 2102\u20132111 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFjhg201678_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta, A., Ricci, R., Widmer, U., Dehout, F., Garcia de Lorenzo, A., Kampmann, C. et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur. J. Clin. Invest. 34, 236\u2013242 (2004).","journal-title":"Eur. J. Clin. Invest."},{"key":"BFjhg201678_CR5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.humpath.2011.07.020","volume":"43","author":"BL Thurberg","year":"2012","unstructured":"Thurberg, B. L. & Politei, J. M. Histologic abnormalities of placental tissues in Fabry disease: a case report and review of the literature. Hum. Pathol. 43, 610\u2013614 (2012).","journal-title":"Hum. Pathol."},{"key":"BFjhg201678_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ijcard.2008.03.007","volume":"130","author":"C Kampmann","year":"2008","unstructured":"Kampmann, C., Linhart, A., Baehner, F., Palecek, T., Wiethoff, C. M., Miebach, E. et al. Onset and progression of the Anderson-Fabry disease related cardiomyopathy. Int. J. Cardiol. 130, 367\u2013373 (2008).","journal-title":"Int. J. Cardiol."},{"key":"BFjhg201678_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","volume":"40","author":"K Sims","year":"2009","unstructured":"Sims, K., Politei, J., Banikazemi, M. & Lee, P. Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke 40, 788\u2013794 (2009).","journal-title":"Stroke"},{"key":"BFjhg201678_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10545-014-9677-8","volume":"37","author":"SM Rombach","year":"2014","unstructured":"Rombach, S. M., Smid, B. E., Linthorst, G.E., Dijkgraaf, M. G. & Hollak, C. E. Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages. J. Inherit. Metab. Dis. 37, 341\u2013352 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFjhg201678_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10545-014-9717-4","volume":"37","author":"LJ Anderson","year":"2014","unstructured":"Anderson, L. J., Wyatt, K. M., Henley, W., Nikolaou, V., Waldek, S., Hughes, D. A. et al. Long-term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS-LSD cohort study. J. Inherit. Metab. Dis. 37, 969\u2013978 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFjhg201678_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1750-1172-8-47","volume":"8","author":"SM Rombach","year":"2013","unstructured":"Rombach, S. M., Smid, B. E., Bouwman, M. G., Linthorst, G. E., Dijkgraaf, M. G. & Hollak, C.E. Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain. Orphanet J. Rare Dis. 8, 47 (2013).","journal-title":"Orphanet J. Rare Dis."},{"key":"BFjhg201678_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/joim.12077","volume":"274","author":"F Weidemann","year":"2013","unstructured":"Weidemann, F., Niemann, M., Stork, S., Breunig, F., Beer, M., Sommer, C. et al. Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J. Intern. Med. 274, 331\u2013341 (2013).","journal-title":"J. Intern. Med."},{"key":"BFjhg201678_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3346\/jkms.2008.23.2.243","volume":"23","author":"JH Choi","year":"2008","unstructured":"Choi, J. H., Cho, Y. M., Suh, K. S., Yoon, H. R., Kim, G. H., Kim, S. S. et al. Short-term efficacy of enzyme replacement therapy in Korean patients with Fabry disease. J. Korean Med. Sci. 23, 243\u2013250 (2008).","journal-title":"J. Korean Med. Sci."},{"key":"BFjhg201678_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W. et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann. Intern. Med. 139, 137\u2013147 (2003).","journal-title":"Ann. Intern. Med."},{"key":"BFjhg201678_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz, G. J., Munoz, A., Schneider, M. F., Mak, R. H., Kaskel, F., Warady, B. A. et al. New equations to estimate GFR in children with CKD. J. Am. Soc. Nephrol. 20, 629\u2013637 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFjhg201678_CR15","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1542\/peds.105.6.1242","volume":"105","author":"RJ Hogg","year":"2000","unstructured":"Hogg, R. J., Portman, R. J., Milliner, D., Lemley, K. V., Eddy, A. & Ingelfinger, J. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics 105, 1242\u20131249 (2000).","journal-title":"Pediatrics"},{"key":"BFjhg201678_CR16","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/0735-1097(92)90385-Z","volume":"20","author":"G de Simone","year":"1992","unstructured":"de Simone, G., Daniels, S. R., Devereux, R. B., Meyer, R. A., Roman, M. J., de Divitiis, O. et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J. Am. Coll. Cardiol. 20, 1251\u20131260 (1992).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFjhg201678_CR17","doi-asserted-by":"publisher","first-page":"175s","DOI":"10.1093\/ajh\/5.6.175S","volume":"5","author":"RB Devereux","year":"1992","unstructured":"Devereux, R. B., Koren, M. J., de Simone, G., Roman, M. J. & Laragh, J. H. Left ventricular mass as a measure of preclinical hypertensive disease. Am. J. Hypertens. 5, 175s\u2013181s (1992).","journal-title":"Am. J. Hypertens."},{"key":"BFjhg201678_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","volume":"52","author":"P Alborzi","year":"2008","unstructured":"Alborzi, P., Patel, N. A., Peterson, C., Bills, J. E., Bekele, D. M., Bunaye, Z. et al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension 52, 249\u2013255 (2008).","journal-title":"Hypertension"},{"key":"BFjhg201678_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/ndt\/gfu273","volume":"30","author":"A Pisani","year":"2015","unstructured":"Pisani, A., Sabbatini, M., Duro, G., Colomba, P. & Riccio, E. Antiproteinuric effect of add-on paricalcitol in Fabry disease patients: a prospective observational study. Nephrol. Dial. Transplant. 30, 661\u2013666 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFjhg201678_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.amjcard.2014.06.019","volume":"114","author":"J Kramer","year":"2014","unstructured":"Kramer, J., Niemann, M., Stork, S., Frantz, S., Beer, M., Ertl, G. et al. Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease. Am. J. Cardiol. 114, 895\u2013900 (2014).","journal-title":"Am. J. Cardiol."},{"key":"BFjhg201678_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/hrt.68.9.323","volume":"68","author":"Y Ikari","year":"1992","unstructured":"Ikari, Y., Kuwako, K. & Yamaguchi, T. Fabry\u2019s disease with complete atrioventricular block: histological evidence of involvement of the conduction system. Br. Heart J. 68, 323\u2013325 (1992).","journal-title":"Br. Heart J."},{"key":"BFjhg201678_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2377-10-38","volume":"10","author":"M Biegstraaten","year":"2010","unstructured":"Biegstraaten, M., van Schaik, I. N., Wieling, W., Wijburg, F. A. & Hollak, C. E. Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests. BMC Neurol. 10, 38 (2010).","journal-title":"BMC Neurol."},{"key":"BFjhg201678_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/hrt.2010.211789","volume":"97","author":"M Namdar","year":"2011","unstructured":"Namdar, M., Steffel, J., Vidovic, M., Brunckhorst, C. B., Holzmeister, J., Luscher, T. F. et al. Electrocardiographic changes in early recognition of Fabry disease. Heart 97, 485\u2013490 (2011).","journal-title":"Heart"},{"key":"BFjhg201678_CR24","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/europace\/eur267","volume":"13","author":"C O\u2019Mahony","year":"2011","unstructured":"O\u2019Mahony, C., Coats, C., Cardona, M., Garcia, A., Calcagnino, M., Murphy, E. et al. Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease. Europace 13, 1781\u20131788 (2011).","journal-title":"Europace"},{"key":"BFjhg201678_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1681\/ASN.2013060585","volume":"25","author":"F Weidemann","year":"2014","unstructured":"Weidemann, F., Kramer, J., Duning, T., Lenders, M., Canaan-Kuhl, S., Krebs, A. et al. Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch. J. Am. Soc. Nephrol. 25, 837\u2013849 (2014).","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg201678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201678","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:35:59Z","timestamp":1684416959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg201678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,23]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["BFjhg201678"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2016.78","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,23]]},"assertion":[{"value":"13 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}